293 related articles for article (PubMed ID: 22018878)
61. [Antitubercular effect of capreomycin in vitro].
Janowiec M
Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
[No Abstract] [Full Text] [Related]
62. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
64. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
65. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
[TBL] [Abstract][Full Text] [Related]
66. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
Tomioka H; Sato K; Saito H
Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
[No Abstract] [Full Text] [Related]
67. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
Reddy MV; Srinivasan S; Gangadharam PR
Tuber Lung Dis; 1994 Jun; 75(3):208-12. PubMed ID: 7919314
[TBL] [Abstract][Full Text] [Related]
68. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS
Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277
[TBL] [Abstract][Full Text] [Related]
69. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
Ahmad Z; Sharma S; Khuller GK
FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
[TBL] [Abstract][Full Text] [Related]
70. Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Jardosh HH; Patel MP
Eur J Med Chem; 2013 Jul; 65():348-59. PubMed ID: 23747804
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
72. Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation.
Ramani AV; Monika A; Indira VL; Karyavardhi G; Venkatesh J; Jeankumar VU; Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2012 Apr; 22(8):2764-7. PubMed ID: 22440626
[TBL] [Abstract][Full Text] [Related]
73. Synthesis and antimycobacterial activity of some phthalimide derivatives.
Akgün H; Karamelekoğlu I; Berk B; Kurnaz I; Sarıbıyık G; Oktem S; Kocagöz T
Bioorg Med Chem; 2012 Jul; 20(13):4149-54. PubMed ID: 22633120
[TBL] [Abstract][Full Text] [Related]
74. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
[TBL] [Abstract][Full Text] [Related]
75. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
[TBL] [Abstract][Full Text] [Related]
76. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
78. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and Antimycobacterial Activity of Isoniazid Derivatives Tethered with Aliphatic Amines.
Pflégr V; Stolaříková J; Vinšová J; Krátký M
Curr Top Med Chem; 2022; 22(32):2695-2706. PubMed ID: 35929626
[TBL] [Abstract][Full Text] [Related]
80. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
